Skip to main content
Livermore
Livermore
ZHEN

Eledon Pharmaceuticals, Inc.

ELDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001404281

No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Eledon Pharmaceuticals, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of ELDN: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders3375+42
Shares18.5M38.5M+20.0M (+108.2%)
Value$46.0M$158.5M+$112.5M (+244.4%)

New holders (45)

Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to ELDN in Q4 2024
InstitutionSharesValue% of portfolio
Ra Capital Management, L.P.3,566,338$14.7M0.20%
First Light Asset Management, LLC2,328,768$9.59M0.92%
Blue Owl Capital Holdings LP1,959,912$8.07M1.91%
Frazier Life Sciences Management, L.P.1,176,735$4.85M0.20%
Ikarian Capital, LLC1,126,637$4.64M1.33%
AWM Investment Company, Inc.1,100,473$4.53M0.55%
Point72 Asset Management, L.P.1,095,000$4.51M0.01%
Sanofi814,980$3.36M1.93%
Boothbay Fund Management, LLC341,923$1.41M0.04%
Velan Capital Investment Management LP323,973$1.33M1.15%
Exome Asset Management LLC256,373$1.06M0.79%
Acuta Capital Partners, LLC235,750$971.3K0.98%
CWM Advisors, LLC194,688$802.1K0.09%
Citadel Advisors LLC189,870$782.3K0.00%
683 Capital Management, LLC154,960$638.4K0.06%
Goldman Sachs Group Inc144,845$596.8K0.00%
Jane Street Group, LLC122,275$503.8K0.00%
Qube Research & Technologies Ltd122,141$503.2K0.00%
Millennium Management LLC118,861$489.7K0.00%
EAM Investors, LLC109,555$451.4K0.06%
Allostery Investments LP100,000$412.0K0.81%
Marshall Wace, LLP80,431$331.4K0.00%
Diadema Partners LP75,794$312.3K0.35%
Prelude Capital Management, LLC74,576$307.3K0.03%
Barclays PLC70,000$288.4K0.00%
Citigroup Inc66,900$275.6K0.00%
Omers Administration Corp62,800$258.7K0.00%
Alps Advisors Inc48,310$199.0K0.00%
Balyasny Asset Management LLC32,623$134.4K0.00%
Kera Capital Partners, Inc.25,770$106.2K0.03%
Cubist Systematic Strategies, LLC24,568$101.2K0.00%
Jefferies Financial Group Inc.22,000$90.6K0.00%
Virtu Financial LLC20,016$82.0K0.00%
Point72 Asia (Singapore) Pte. Ltd.18,379$75.7K0.02%
Persistent Asset Partners Ltd14,855$67.1K0.06%
ADAR1 Capital Management, LLC16,000$65.9K0.01%
Alpine Global Management, LLC13,471$55.5K0.02%
Connor, Clark & Lunn Investment Management Ltd.11,303$46.6K0.00%
Simplex Trading, LLC10,437$43.0K0.00%
Point72 (DIFC) Ltd4,462$18.4K0.00%
Addison Advisors LLC1,300$5.36K0.00%
Jones Financial Companies LLLP625$2.58K0.00%
Group One Trading, L.P.591$2.44K0.00%
Insight Financial Services100$4120.00%
SBI Securities Co., Ltd.43$1770.00%

Sold out (3)

Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of ELDN in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Armistice Capital, LLC2,364,000$5.89M
Two Sigma Securities, LLC11,027$27.5K
JPMorgan Chase & Co97$242